Hematology News

Withholding prophylactic platelet transfusion before placement of a central venous catheter in patients with severe thrombocytopenia resulted in more catheter-related bleeding events, results of a randomized noninferiority trial showed.

The FDA approved avapritinib for treatment of adults with indolent systemic mastocytosis, according to a press release from the agent’s manufacturer.

Treatment with exagamglogene autotemcel conferred clinically meaningful increases in fetal hemoglobin and total hemoglobin levels among patients with beta-thalassemia and sickle cell disease, results of two pivotal studies showed.

Unemployment, depression, female sex and older age appeared associated with increased pain frequency among patients with sickle cell disease, according to study results published in JAMA Network Open.

Despite having been established as the primary disease-modifying therapy for individuals with sickle cell anemia, hydroxyurea remains underused among children with the disease, according to data published in JAMA Network Open.

Active surveillance by implanting physicians appeared linked to improved retrieval of inferior vena cava filters, according to results of a retrospective cohort study.

The Ivenix Infusion System has been recalled by its manufacturer due to a system leak that may compromise the ability of the equipment to properly deliver infusions, according to press release from the FDA.

Cardiovascular disease, especially atherosclerotic CVD, was associated with increased risk for cancer diagnosis, according to a study published in JACC: CardioOncology.

Results of a large meta-analysis indicated that Black race was associated with greater odds of cardiotoxicity and HF diagnosis after chemotherapy compared with white and non-Black race, a speaker reported.

The sex of red blood cell donors did not have a significant impact on survival outcomes of transfusion recipients, according to study results published in The New England Journal of Medicine.